Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

被引：1
|
作者：
Sadowska-Klasa, Alicja [1 ,2 ]
Ozkok, Sezen [1 ]
Xie, Hu [1 ]
Leisenring, Wendy [1 ,3 ]
Zamora, Danniel [1 ,3 ]
Seo, Sachiko [4 ]
Sheldon, Jordan [1 ]
Lee, Stephanie J. [1 ,3 ]
Green, Margaret L. [1 ,3 ]
Boeckh, Michael [1 ,3 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Med Univ Gdansk, Hematol & Transplantol, Gdansk, Poland
[3] Univ Washington, Seattle, WA 98195 USA
[4] Dokkyo Med Univ, Dept Hematol & Oncol, Shimotsuke, Tochigi, Japan
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] NK Cell Immunity Pre-Transplant as a Predictor for CMV Post-Transplant
    Keshwani, S.
    Humar, A.
    Lisboa, L.
    Egli, A.
    Bochud, P.
    Hirsch, H.
    Weisser, M.
    Husain, S.
    Garzoni, C.
    van Delden, C.
    Manuel, O.
    Meylan, P.
    Boggian, K.
    Stern, M.
    Rick, J.
    Mueller, N.
    Kumar, D.
    TRANSPLANTATION, 2014, 98 : 178 - 178
  • [42] Post-transplant cyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia
    Borovkova, Anastasya Svyatoslavovna
    Paina, Olesya Vladimirovna
    Semenova, Elena Vladimirovna
    Bykova, Tatiana Alexandrovna
    Osipova, Anna Alekseevna
    Slesarchuk, Olga Alexandrovna
    Kozhokar, Polina Valerievna
    Tsvetkova, Lubov Alexandrovna
    Rakhmanova, Zhemal Zarifovna
    Kozlov, Andrei Vadimovich
    Chukhlovin, Alexei Borisovich
    Kazantsev, Ilya Viktorovich
    Estrina, Maria Arkadievna
    Goloshchapov, Oleg Valerievich
    Bondarenko, Sergei Nikolaevich
    Moiseev, Ivan Sergeevich
    Kulagin, Alexander Dmitrievich
    Zubarovskaya, Ludmila Stepanovna
    CLINICAL TRANSPLANTATION, 2024, 38 (01)
  • [43] Favorable Immune Reconstitution Profile after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Jamy, Omer Hassan
    Saad, Ayman
    Orlandella, Rachael
    Langford, Samantha B.
    Paluri, Ravi K.
    Innis-Shelton, Racquel
    Mineishi, Shin
    Lamb, Lawrence S., Jr.
    BLOOD, 2016, 128 (22)
  • [44] Impact of Post-Transplant High-Dose Cyclophosphamide and Donor Sources on CMV Reactivation
    Martin, James Michael
    Senchak, Jordan
    Tan, Carlyn Rose
    Pancari, Philip A.
    Cael, Brittany
    Devarajan, Karthik
    Barta, Stefan K.
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [45] Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant
    Prockop, Susan E.
    Hasan, Aisha
    Koehne, Guenther
    Doubrovina, Ekaterina
    Sauter, Craig S.
    Barker, Juliet N.
    Baroudy, Karim
    Boulad, Farid
    Giralt, Sergio
    Khalaf, Ramzi
    Kernan, Nancy A.
    Papadopoulos, Esperanza B.
    Ponce, Doris M.
    Scaradavou, Andromachi
    Suser, Stephanie
    Wasilewski, Gloria
    O'Reilly, Richard J.
    BLOOD, 2014, 124 (21)
  • [46] CMV Viral Load after Peripheral Blood Stem Cell Transplantation (PBSCT) and Posttransplant High-Dose Cyclophosphamide (PTCy)
    Ueda, Masumi
    Mielcarek, Marco B.
    Sandmaier, Brenda M.
    Xie, Hu
    Davis, Chris
    Gooley, Ted A.
    Boeckh, Michael J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [47] CMV infection in the haploidentical transplant (HAPLO) with post-transplant cyclophosphamide (PTCY): One center's experience
    Cabero Martinez, Almudena
    Fernandez Luis, Sara
    Fernandez Martinez, Cristina
    Garcia Avila, Sara
    Insunza Gaminde, Andres
    Sanchez Escamilla, Miriam
    Mora Barrios, Joan Manuel
    Gonzalez Romero, Yolanda
    Gomez Lamas, David
    Yanez San Segundo, Lucrecia
    Colorado Araujo, Mercedes
    Lopez Duarte, Monica
    Nunez Cespedes, Javier
    Martin Sanchez, Guillermo
    Casado Fernandez, Amaia
    Cortes Vazquez, Miguel Angel
    Richard Espiga, Carlos
    Ocio San Miguel, Enrique
    Bermudez Rodriguez, Maria Aranzazu
    BONE MARROW TRANSPLANTATION, 2019, 54 : 401 - 402
  • [48] Recovery of CMV Specific T Cells Following Alternative Donor Allogeneic Transplant with Post-Transplant Cyclophosphamide
    Lamb, L.
    Saad, A.
    Mineishi, S.
    Langford, S.
    Di Stasi, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S150 - S151
  • [49] Risk factors for development of CMV disease after allogeneic stem cell transplantation in the era of viral load monitoring
    Ljungman, P
    Pérez-Bercoff, L
    Jonsson, J
    Sparrelid, E
    Aschan, J
    Barkholt, L
    Larsson, K
    Lewensohn-Fuchs, I
    Winiarski, J
    Yun, Z
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2005, 35 : S27 - S27
  • [50] CMV viral load kinetics as surrogate endpoints after allogenic transplantation
    Duke, Elizabeth R.
    Williamson, Brian D.
    Borate, Bhavesh
    Golob, Jonathan L.
    Wychera, Chiara
    Stevens-Ayers, Terry
    Huang, Meei-Li
    Cossrow, Nicole
    Wan, Hong
    Mast, T. Christopher
    Marks, Morgan A.
    Flowers, Mary E.
    Jerome, Keith R.
    Corey, Lawrence
    Gilbert, Peter B.
    Schiffer, Joshua T.
    Boeckh, Michael
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01):
12345